{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-090153","form_type":"8-K","ticker":"ARMP","cik":"0000921114","company_name":"Armata Pharmaceuticals, Inc.","filed_at":"2024-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.364455+00:00","generated_at":"2026-05-31T09:11:55.516420+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Armata appoints David House as SVP, Finance and principal financial officer","bullets":["David House appointed SVP, Finance and principal financial officer, effective Aug. 16, 2024.","Base salary $350,000; target bonus 40% of base; option for 75,000 shares vesting over 4 years.","Previously Corporate Controller and VP of Accounting at ZO Skin Health (acquired by Blackstone).","Prior principal financial officer Richard Rychlik will remain as Corporate Controller."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-090153","json":"https://secwatch.observer/filing/0001104659-24-090153.json","markdown":"https://secwatch.observer/filing/0001104659-24-090153.md","text":"https://secwatch.observer/filing/0001104659-24-090153.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/921114/000110465924090153/0001104659-24-090153-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/921114/000110465924090153/tm2421653d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:11:55.516420+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8a25ce94d0","claim":"David House was appointed as Senior Vice President, Finance at Armata Pharmaceuticals, Inc..","evidence_excerpt":"On July 31, 2024, Armata Pharmaceuticals, Inc. (the “ Company ”) entered into an employment letter agreement (the “ Agreement ”) with David House, pursuant to which he has agreed to serve as the Company’s Senior Vice President, Finance, effective August 16, 2024 (the “ Effective Date ”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/921114/000110465924090153/0001104659-24-090153-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Senior Vice President, Finance"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}